Standards Development for Prescription Drug Supply Chain Security

FDA has been developing standards for further securing the drug supply chain pursuant to Section 913 of the Food and Drug Administration Amendments Act of 2007 (FDAAA). This act states that, “the Secretary shall develop standards and identify and validate effective technologies for the purpose of securing the drug supply chain against counterfeit, diverted, subpotent, substandard, adulterated, misbranded, or expired drugs.” FDA will also be developing standards pursuant to the Drug Supply Chain Security Act.

Page Last Updated: 06/02/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English